>> Continued From the Previous Page <<
“If we just gave good food, three meals a day, to every man, woman, and child in our country, we could solve the obesity and diabetes epidemic overnight,” Kennedy said.
But Elon Musk, who has quickly become one of Trump’s closest advisors, broke with Kennedy and delivered a strong defense of GLP-1 drugs like Ozempic. Musk’s comments immediately drew attention across the political spectrum.
“Nothing would do more to improve the health, lifespan, and quality of life for Americans than making GLP inhibitors super low cost to the public,” Musk posted on X (formerly Twitter). “Nothing else is even close.”
Whoopi Goldberg Takes Musk’s Side
It’s no secret that The View hosts rarely have anything positive to say about Elon Musk. Since his purchase of Twitter and public endorsements of Trump, Musk has been a consistent target for ridicule.
But in a twist no one saw coming, Whoopi Goldberg took Musk’s side during a segment discussing the weight-loss drug controversy. Goldberg pushed back against claims that weight issues are simply a result of poor eating habits.
“This isn’t just about food. This is sometimes people are born genetically larger,” Goldberg said, arguing that obesity is a far more complex issue than some realize.
Goldberg also shared her personal experience with weight-loss medications.
Gold at $2,600… But This Stock Gives You More for Under $20
“I began taking Mounjaro when I weighed nearly 300 pounds, and I saw amazing weight loss results,” she revealed.
In a direct response to Kennedy’s comments, Goldberg suggested his remarks were out of touch with the reality faced by millions of Americans struggling with obesity.
“You’re setting folks up for shame,” Goldberg said. “Maybe you don’t know you’re doing it… but it doesn’t work for everybody.”
Joy Behar and Alyssa Farah Griffin Weigh In
Joy Behar, another View co-host, dismissed concerns about the drugs’ side effects, such as nausea and vomiting, as exaggerated.
“The side effects are not horrible,” Behar argued, pushing back on critics who have questioned the safety of GLP-1 medications.
Then came the moment that shocked viewers the most. Alyssa Farah Griffin, a conservative voice on the panel, agreed with Musk’s stance.
“Elon’s right on this,” Griffin said, drawing murmurs from the audience.
Even Goldberg echoed the sentiment, adding, “Elon’s right on this!”
Kennedy Softens His Stance
After the backlash, Kennedy appeared to soften his stance slightly. Speaking with CNBC’s Jim Cramer at the New York Stock Exchange, Kennedy clarified his position.
“The first line of response should be lifestyle. It should be eating well, making sure that you don’t get obese, and that those GLP drugs have a place,” he said.
While Kennedy’s remarks left room for compromise, it’s clear that the debate over weight-loss drugs is far from settled.
A Rare Moment of Agreement
For once, Americans saw an unexpected moment of agreement between Elon Musk and his critics on the Left. While tensions remain high between Musk and the mainstream media, his defense of Ozempic and other GLP-1 drugs has bridged an unlikely gap.
Whether this newfound support will last is anyone’s guess, but for now, one thing is clear: Musk’s influence on the national conversation is impossible to ignore—even among his staunchest critics.
